Status:
TERMINATED
Sarcopenia in the Acute Stroke
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Regardless of the cause of immobilization, within days or weeks there is rapidly a decrease in strength and muscle mass, which can lead to sarcopenia. In severe strokes, immobilization and neurologic ...
Detailed Description
In stroke patients, muscle damage combines many mechanisms such as immobilization, nutritional disorders , sympathetic activity, inflammation and denervation . These general factors explain that post-...
Eligibility Criteria
Inclusion
- Acute stroke patient
- Over 18 years of age
- Functional Ambulation Categories (FAC) \< 3
- NIHSS upper limb score ≥ 1
- Able to understand assessment instructions
- Non-objection to the study
- Affiliated with a social security scheme
Exclusion
- Person under guardianship or curatorship.
- Person deprived of liberty
- Person under court protection
- Other neurological or rheumatological pathology limiting mobility
- Presence of a pacemaker or defibrillator.
- Pregnant or breast-feeding woman
Key Trial Info
Start Date :
June 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 6 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06603701
Start Date
June 28 2024
End Date
August 6 2024
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'ORLEANS
Orléans, France, 45067